Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP621408.RAAVVK2nMlToLAyfbYoSI9o9zYlHsR7xHOsRijWjvYljE130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621408.RAAVVK2nMlToLAyfbYoSI9o9zYlHsR7xHOsRijWjvYljE130_provenance.
• NP732531.RAAYFnwDNI8C2Y4qJpfqxPfnqUAQxjMfnLDF1SSk4N-Po130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732531.RAAYFnwDNI8C2Y4qJpfqxPfnqUAQxjMfnLDF1SSk4N-Po130_provenance.
• NP732533.RACaPE3Q5ovbgGrlAHzQXBEiZFraevlgTDLBGP0yoVE_8130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732533.RACaPE3Q5ovbgGrlAHzQXBEiZFraevlgTDLBGP0yoVE_8130_provenance.
• NP483592.RAziHmND-nLqyxnkXYb1yWto4tGCJUWouEyM--l5emL7U130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483592.RAziHmND-nLqyxnkXYb1yWto4tGCJUWouEyM--l5emL7U130_provenance.
• NP232364.RAJ3sZq3FuVr7Vqo09VXq42Uyk-n9pw5iMXjq_YGiNQk8130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232364.RAJ3sZq3FuVr7Vqo09VXq42Uyk-n9pw5iMXjq_YGiNQk8130_provenance.
• NP484194.RAMsKz2ZDRcne4xqUcmuJ2iZmbnp-hPiommFjGqA_ex2M130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484194.RAMsKz2ZDRcne4xqUcmuJ2iZmbnp-hPiommFjGqA_ex2M130_provenance.
• NP732530.RAXXeSQBNj0J57R-cwbIkISpasX2hoW3R9y-Zhp5NkR-Y130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732530.RAXXeSQBNj0J57R-cwbIkISpasX2hoW3R9y-Zhp5NkR-Y130_provenance.
• NP622749.RAMy2VlWx4THzF-tKF703ZoUu8EM7zBEzUjEj03Dz_EFU130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622749.RAMy2VlWx4THzF-tKF703ZoUu8EM7zBEzUjEj03Dz_EFU130_provenance.
• NP624065.RAOtGX80WcvWC8ajKxDIM8GYmVSsEyVCta0ETguFFckrc130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624065.RAOtGX80WcvWC8ajKxDIM8GYmVSsEyVCta0ETguFFckrc130_provenance.
• NP625205.RAExrR9yGNnTgD7kZY0Nh7R8LFbqLx-TkHwZpf1pH6UOo130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625205.RAExrR9yGNnTgD7kZY0Nh7R8LFbqLx-TkHwZpf1pH6UOo130_provenance.
• assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP732532.RAIj5Oi3KexauUdoDPX08vir76ak7AA3C8srSedxQs2ck130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732532.RAIj5Oi3KexauUdoDPX08vir76ak7AA3C8srSedxQs2ck130_provenance.
• NP732528.RAqNRBnEX6T8xnjX4tEBI3rIiEcD_3EmPkQXwevzs5Pnw130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732528.RAqNRBnEX6T8xnjX4tEBI3rIiEcD_3EmPkQXwevzs5Pnw130_provenance.
• NP732529.RAvMjLVymEbKs503UO_KWK8uJyEDHe1DTZhqIGGBnB6tE130_assertion description "[We also found that expression levels of the ret proto-oncogene, insulin-like growth factor 1 receptor, and insulin-like growth factor 2 correlate with poor metastasis-free survival, supporting a role for ERK/MAPK and PI3K/AKT pathways in clinically aggressive myxoid liposarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732529.RAvMjLVymEbKs503UO_KWK8uJyEDHe1DTZhqIGGBnB6tE130_provenance.